pivaloylcarnitine has been researched along with s 1108 in 3 studies
Studies (pivaloylcarnitine) | Trials (pivaloylcarnitine) | Recent Studies (post-2010) (pivaloylcarnitine) | Studies (s 1108) | Trials (s 1108) | Recent Studies (post-2010) (s 1108) |
---|---|---|---|---|---|
26 | 1 | 7 | 67 | 20 | 16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, H; Konishi, M | 1 |
Konishi, M; Shimizu, K; Totsuka, K; Yamamoto, S | 1 |
Matsuno, S; Mizojiri, K; Nakashima, M; Oguma, T; Uematsu, T; Yamamoto, S; Yoshida, T | 1 |
1 trial(s) available for pivaloylcarnitine and s 1108
Article | Year |
---|---|
Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores.
Topics: Adult; Carnitine; Cephalosporins; Drug Administration Schedule; Drug Evaluation; Humans; Male; Pentanoic Acids; Tablets | 1992 |
2 other study(ies) available for pivaloylcarnitine and s 1108
Article | Year |
---|---|
Determination of pivaloylcarnitine in human plasma and urine by high-performance liquid chromatography with fluorescence detection.
Topics: Calibration; Carnitine; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Humans; Pentanoic Acids; Prodrugs; Quinoxalines; Sensitivity and Specificity; Spectrometry, Fluorescence | 1992 |
Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Carnitine; Cephalosporins; Humans; Male; Pentanoic Acids | 1992 |